A61K 31/5355
Non-condensed oxazines and containing further heterocyclic rings
A61K31/5355 (Non-condensed oxazines and containing further heterocyclic rings) appears on 256 US grants and 430 published applications in this corpus.
Search patents in A61K- Granted patents
- 256
- Published applications
- 430
- Assignees
- 245
- Inventors
- 1,302
- Latest grant
- 1 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 6 | 0 |
| 1997 | 5 | 0 |
| 1998 | 2 | 0 |
| 1999 | 6 | 0 |
| 2000 | 2 | 0 |
| 2001 | 2 | 2 |
| 2002 | 1 | 7 |
| 2003 | 2 | 7 |
| 2004 | 2 | 7 |
| 2005 | 7 | 9 |
| 2006 | 1 | 5 |
| 2007 | 4 | 7 |
| 2008 | 4 | 10 |
| 2009 | 4 | 5 |
| 2010 | 5 | 14 |
| 2011 | 1 | 7 |
| 2012 | 7 | 12 |
| 2013 | 8 | 18 |
| 2014 | 14 | 21 |
| 2015 | 19 | 27 |
| 2016 | 13 | 19 |
| 2017 | 13 | 25 |
| 2018 | 18 | 26 |
| 2019 | 23 | 30 |
| 2020 | 16 | 28 |
| 2021 | 13 | 28 |
| 2022 | 18 | 23 |
| 2023 | 20 | 18 |
| 2024 | 8 | 33 |
| 2025 | 8 | 24 |
| 2026 | 4 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Large-conductance potassium channel modulators, compositions thereof, methods of manufacturing thereof, and methods of use thereof1 Sep 2026US 12,721,850 B2Enalare Therapeutics Inc.
- Methods for treating intracranial hemorrhage and assessing efficacy21 Jul 2026US 12,685,763 B2Alexion Pharmaceuticals, Inc.
- Small molecule inhibitors of TLR2 signaling16 Jun 2026US 12,653,800 B2University of Maryland, Baltimore
- Compositions and methods for the treatment of Plasmodium falciparum malaria10 Feb 2026US 12,544,357 B2Brown University
- Compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders18 Nov 2025US 12,472,181 B2Galapagos NV
- Substituted acetylene compound derivatives and their pharmaceutical use1 Oct 2026US 2026/0297083 A1Avelos Therapeutics Inc.
- Compounds for positive modulation of the autophagy-lysosomal pathway and methods of use27 Aug 2026US 2026/0250256 A1
- Methods of reducing transplant rejection in subjects undergoing immunosuppressant therapy20 Aug 2026US 2026/0240870 A1University of Maryland, Baltimore
- Combinations of anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use13 Aug 2026US 2026/0232620 A1Genentech, Inc.
- Novel compounds and pharmaceutical compositions thereof for the treatment of inflammatory disorders2 Jul 2026US 2026/0183288 A1Galapagos NV
Most cited
By later US patents
- Benzothiophene compounds intermediate compositions and methods for inhibiting aortal smooth muscle proliferation98US 5,492,922 AEli Lilly and Company · 1996
- Regulation of wound healing by nitric oxide75US 6,190,704 B1New York Society for the Ruptured and Crippled Maintaining the Hospital for Special Surgery · 2001
- Pharmaceutical compounds65US 7,781,433 B2Piramed Limited · 2010
- Benzothiophene compounds as anti-estrogenic agents55US 5,510,357 AEli Lilly and Company · 1996
- CB.sub.2 Receptor agonist compounds55US 6,013,648 ASanofi · 2000